Monroe Capital inks deal with diagnostics company

The $30 million senior secured credit facility will support the company's growth initiatives.

Monroe Capital, the Chicago-based lender, has closed on a $30 million senior secured credit facility with a diagnostic services company, which Monroe declined to name. The firm acted as the sole lead arranger and administrative agent in the transaction, Monroe announced yesterday (12 November). The deal is meant to support the growth of the company. 

The diagnostic services company is based in the Southwestern US. The company provides specialized toxicology and pathology diagnostic lab testing services to clinical healthcare providers including urine drug monitoring for pain management, addiction medicine and other outpatient screening / compliance monitoring services. The company also deals in standardized gastrointestinal and dermatological lab testing services. 

Monroe Capital provides senior and junior debt and equity co-investments to mid-market companies in the US and Canada. Investment types include unitranche financings, cash flow and enterprise value based loans, acquisition facilities, mezzanine debt, second lien or last-out loans and equity co-investments.